Entrada Therapeutics, Inc.
TRDA
DELAYED 1 MONTH
10 insider filings · Latest: May 20, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | May 21 8:31 PM | Bernhardt G ZeiherDirector | Purchase | 5,000 | $5.86 | $29.3K | 5,000(I) | View → |
| May 4, 2026 | May 4 11:25 PM | Natarajan SethuramanPresident, Research & Develop. | Sale | 25,907 | $15.39 | $398.8K | 216,317(D) | View → |
| May 4, 2026 | May 4 11:24 PM | Nathan J DowdenPresident & COO | Sale | 15,000 | $15.33 | $230.0K | 198,588(D) | View → |
| Mar 10, 2026 | Mar 11 8:35 PM | Nathan J DowdenPresident & COO | Sale | 11,894 | $13.05 | $155.2K | 198,588(D) | View → |
| Mar 9, 2026 | Mar 11 8:35 PM | Nathan J DowdenPresident & COO | Sale | 3,116 | $13.02 | $40.6K | 210,482(D) | View → |
| Mar 10, 2026 | Mar 11 8:34 PM | Kory James WentworthChief Financial Officer | Sale | 11,388 | $13.02 | $148.2K | 121,510(D) | View → |
| Mar 9, 2026 | Mar 11 8:34 PM | Kory James WentworthChief Financial Officer | Sale | 5,089 | $13.00 | $66.2K | 132,898(D) | View → |
| Mar 4, 2026 | Mar 6 9:36 PM | Kory James WentworthChief Financial Officer | Sale | 7,988 | $12.25 | $97.9K | 137,987(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | May 4 11:24 PM | Nathan J DowdenPresident & COO | Option Exercise | 15,000 | $1.74 | 49,831(D) | View → |
| Mar 1, 2026 | Mar 3 11:21 PM | Dipal DoshiDirector, CEO | Grant/Award | 208,000 | $11.93 | 208,000(D) | View → |
| Mar 1, 2026 | Mar 3 11:20 PM | Kory James WentworthChief Financial Officer | Grant/Award | 66,600 | $11.93 | 66,600(D) | View → |
| Mar 1, 2026 | Mar 3 11:19 PM | Nathan J DowdenPresident & COO | Grant/Award | 83,200 | $11.93 | 83,200(D) | View → |
| Mar 1, 2026 | Mar 3 11:18 PM | Natarajan SethuramanPresident, Research & Develop. | Grant/Award | 83,200 | $11.93 | 83,200(D) | View → |